CIK 0001853816
- Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 858-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Nardo Christopher J. Senior VP, CDO | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2025-01-13 | Nardo Christopher J. Senior VP, CDO | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-01-04 | Nardo Christopher J. Senior VP, CDO | Grant or award · Stock Option (right to buy | +50,000 | 50,000 | ||
| 2023-01-03 | Nardo Christopher J. Senior VP, CDO | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-07-01 | Nardo Christopher J. Senior VP, CDO | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-01-03 | Nardo Christopher J. Senior VP, Development | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-08-17 | Nardo Christopher J. Senior VP, Development | Conversion | +2,439 | 2,439 | ||
| 2021-08-17 | Nardo Christopher J. Senior VP, Development | Conversion · Series 1 Preferred Stock | −50,000 | 0 |
Page 1 of 1 · 8 trades